110 related articles for article (PubMed ID: 31999272)
1. [Spice intoxication and hyperglycemia].
Elena-González A; Cuadros-Tito P; Esteban-Gutiérrez G
An Sist Sanit Navar; 2020 Apr; 43(1):87-91. PubMed ID: 31999272
[TBL] [Abstract][Full Text] [Related]
2. A diabetic ketoacidosis in a context of hyperglycemia addiction.
Rousseau G; Palmiere C; Dupont V; Verschoore M; Savary C; Jousset N; Rougé-Maillart C
Int J Legal Med; 2018 May; 132(3):787-790. PubMed ID: 29034415
[TBL] [Abstract][Full Text] [Related]
3. Life-Threatening Bleeding and Deaths from Synthetic Cannabinoids.
Zolot J
Am J Nurs; 2019 Mar; 119(3):15. PubMed ID: 30801303
[TBL] [Abstract][Full Text] [Related]
4. Psychopathological symptoms associated with synthetic cannabinoid use: a comparison with natural cannabis.
Mensen VT; Vreeker A; Nordgren J; Atkinson A; de la Torre R; Farré M; Ramaekers JG; Brunt TM
Psychopharmacology (Berl); 2019 Sep; 236(9):2677-2685. PubMed ID: 30968175
[TBL] [Abstract][Full Text] [Related]
5. Emergence of new classes of recreational drugs-synthetic cannabinoids and cathinones.
Khullar V; Jain A; Sattari M
J Gen Intern Med; 2014 Aug; 29(8):1200-4. PubMed ID: 24553958
[TBL] [Abstract][Full Text] [Related]
6. Psychotic Disorders in Patients Who Use Synthetic Cannabinoids.
Skryabin VY; Vinnikova MA
J Psychiatr Pract; 2019 Nov; 25(6):485-490. PubMed ID: 31821228
[TBL] [Abstract][Full Text] [Related]
7. [Toxicology of synthetic cannabinoids].
Mouraouakkil Y; Mounir R; El Cadi MA; Lamsaouri J; Bousliman Y; ElJaoudi R
Ann Biol Clin (Paris); 2024 Jun; 82(2):151-173. PubMed ID: 38721719
[TBL] [Abstract][Full Text] [Related]
8. Spice/K2 synthetic marijuana-induced toxic hepatitis treated with N-acetylcysteine.
Sheikh IA; Lukšič M; Ferstenberg R; Culpepper-Morgan JA
Am J Case Rep; 2014 Dec; 15():584-8. PubMed ID: 25548903
[TBL] [Abstract][Full Text] [Related]
9. Algorithm that delivers an individualized rapid-acting insulin dose after morning resistance exercise counters post-exercise hyperglycaemia in people with Type 1 diabetes.
Turner D; Luzio S; Gray BJ; Bain SC; Hanley S; Richards A; Rhydderch DC; Martin R; Campbell MD; Kilduff LP; West DJ; Bracken RM
Diabet Med; 2016 Apr; 33(4):506-10. PubMed ID: 26220149
[TBL] [Abstract][Full Text] [Related]
10. Treatment of prednisolone-induced hyperglycaemia in hospitalized patients: Insights from a randomized, controlled study.
Radhakutty A; Stranks JL; Mangelsdorf BL; Drake SM; Roberts GW; Zimmermann AT; Stranks SN; Thompson CH; Burt MG
Diabetes Obes Metab; 2017 Apr; 19(4):571-578. PubMed ID: 27995731
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of mitiglinide combined with once daily insulin glargine after switching from multiple daily insulin regimen of aspart insulin and glargine in patients with type 2 diabetes mellitus.
Yoshihara T; Kumashiro N; Kanazawa Y; Mita T; Sakurai Y; Kawai J; Abe M; Motojima K; Hara K; Yamazaki Y; Kanazawa A; Miwa S; Sato F; Kanno R; Shimizu T; Sakai K; Uchino H; Watada H; Tanaka Y; Kawamori R; Hirose T
Endocr J; 2006 Feb; 53(1):67-72. PubMed ID: 16543674
[TBL] [Abstract][Full Text] [Related]
12. A review on the abuse of three NPS (synthetic cannabinoids, kratom, poppers) among youths in Asia.
Bae K; Kwon NJ; Han E
Forensic Sci Int; 2018 Nov; 292():45-49. PubMed ID: 30273913
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal manifestations of synthetic cannabinoids: a retrospective cohort study.
Hakimian D; Benson AA; Khoury T; Massarwa M; Israel S; Salameh S; Gershinsky Y; Shapira B; Muszkat M
BMC Gastroenterol; 2021 Jul; 21(1):274. PubMed ID: 34229620
[TBL] [Abstract][Full Text] [Related]
14. Synthetic cannabinoids and potential reproductive consequences.
Sun X; Dey SK
Life Sci; 2014 Feb; 97(1):72-7. PubMed ID: 23827241
[TBL] [Abstract][Full Text] [Related]
15. Glycemic Control in Adult Surgical Patients Receiving Regular Insulin Added to Parenteral Nutrition vs Insulin Glargine: A Retrospective Chart Review.
Truong S; Park A; Kamalay S; Hung N; Meyer JG; Nguyen N; Momenzadeh A
Nutr Clin Pract; 2019 Oct; 34(5):775-782. PubMed ID: 30693980
[TBL] [Abstract][Full Text] [Related]
16. Management of hyperglycemia in diabetic patients with hematologic malignancies during dexamethasone therapy.
Gosmanov AR; Goorha S; Stelts S; Peng L; Umpierrez GE
Endocr Pract; 2013; 19(2):231-5. PubMed ID: 23337144
[TBL] [Abstract][Full Text] [Related]
17. Severe hypoglycaemia in adults with insulin-treated diabetes: impact on healthcare resources.
Heller SR; Frier BM; Hersløv ML; Gundgaard J; Gough SC
Diabet Med; 2016 Apr; 33(4):471-7. PubMed ID: 26179360
[TBL] [Abstract][Full Text] [Related]
18. Synthetic drug intoxication in children: recognition and management in the emergency department.
Shah R; Baum CR
Pediatr Emerg Med Pract; 2018 May; 15(5):1-20. PubMed ID: 29697923
[TBL] [Abstract][Full Text] [Related]
19. Fiasp--another insulin aspart formulation for diabetes.
Med Lett Drugs Ther; 2018 Jan; 60(1537):6-7. PubMed ID: 29294464
[No Abstract] [Full Text] [Related]
20. In Brief: Semglee - a new insulin glargine for diabetes.
Med Lett Drugs Ther; 2021 Jan; 63(1616):14-15. PubMed ID: 33512347
[No Abstract] [Full Text] [Related]
[Next] [New Search]
